R Dong, Y Zhang, H Xiao, X Zeng - Frontiers in immunology, 2022 - frontiersin.org
Adoptive cell therapy (ACT) with engineered T cells has emerged as a promising strategy for
the treatment of malignant tumors. Among them, there is great interest in engineered γδ T …